The role of iron supplementation during epoietin treatment for cancer-related anemia (Q37160441)

18 August 2017

1 reference

title

The role of iron supplementation during epoietin treatment for cancer-related anemia (English)

1 reference

18 August 2017

M Hedenus

1

1 reference

18 August 2017

G Birgegård

series ordinal

2

1 reference

18 August 2017

publication date

13 May 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

26

1 reference

18 August 2017

issue

1

1 reference

18 August 2017

page(s)

105-115

1 reference

https://scigraph.springernature.com/pub.10.1007/s12032-008-9072-0

18 August 2017

exact match

0 references

cites work

Biological basis of anemia

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12032-008-9072-0

IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12032-008-9072-0

Iron stores and serum transferrin receptor levels during recombinant human erythropoietin treatment of anemia in rheumatoid arthritis

21 January 2018

1 reference

12 December 2020

Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study

1 reference

12 December 2020

Ferritin synthesis in inflammation. I. Pathogenesis of impaired iron release

1 reference

12 December 2020

What is the most appropriate strategy to monitor functional iron deficiency in the dialysed patient on rhEPO therapy? Merits of percentage hypochromic red cells as a marker of functional iron deficiency

1 reference

12 December 2020

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update

1 reference

12 December 2020

The diagnostic plot: a concept for identifying different states of iron deficiency and monitoring the response to epoetin therapy

1 reference

12 December 2020

Labile iron in parenteral iron formulations: a quantitative and comparative study

1 reference

12 December 2020

EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients.

1 reference

12 December 2020

Strategies for iron supplementation: oral versus intravenous

1 reference

12 December 2020

Clinical utility of the reticulocyte hemoglobin content in the diagnosis of iron deficiency

1 reference

12 December 2020

Should we still use iron dextran in hemodialysis patients?

1 reference

12 December 2020

Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review

1 reference

12 December 2020

Randomized phase III trial evaluating the role of erythropoietin in the prevention of chemotherapy-induced anemia

1 reference

12 December 2020

Chronic hepcidin induction causes hyposideremia and alters the pattern of cellular iron accumulation in hemochromatotic mice

1 reference

12 December 2020

Role of iron in optimizing responses of anemic cancer patients to erythropoietin.

1 reference

12 December 2020

Hepcidin excess induces the sequestration of iron and exacerbates tumor-associated anemia

1 reference

12 December 2020

Iron, anaemia, and inflammatory bowel diseases.

1 reference

12 December 2020

Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes and Practice Patterns Study (DOPPS) findings.

1 reference

12 December 2020

Anemia of inflammation: the hepcidin link

1 reference

12 December 2020

Anemia of chronic disease.

1 reference

12 December 2020

Pharmacokinetics and red cell utilization of iron(III) hydroxide-sucrose complex in anaemic patients: a study using positron emission tomography

1 reference

12 December 2020

Iron and erythropoietin in renal disease

1 reference

12 December 2020

II. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults

1 reference

12 December 2020

Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases

1 reference

12 December 2020

Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia.

1 reference

12 December 2020

The role of iron in cancer

1 reference

12 December 2020

Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients

1 reference

12 December 2020

Intravenous Iron Sucrose versus Oral Iron Supplementation for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease-A Randomized, Controlled, Open-Label, Multicenter Study

1 reference

12 December 2020

Economic evaluation in Sweden of epoetin beta with intravenous iron supplementation in anaemic patients with lymphoproliferative malignancies not receiving chemotherapy.

1 reference

12 December 2020

Time-dependent associations between iron and mortality in hemodialysis patients

1 reference

12 December 2020

Pathogenesis of hepatocellular carcinoma in hereditary hemochromatosis: occurrence in noncirrhotic patients

1 reference

12 December 2020

Darbepoetin alpha for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation

1 reference

12 December 2020

Pharmacokinetics of iron(III)-hydroxide sucrose complex after a single intravenous dose in healthy volunteers

1 reference

12 December 2020

Benefits and risks of iron therapy for chronic anaemias

1 reference

12 December 2020

Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy.

1 reference

12 December 2020

Supplemental Iron: A Key to Optimizing the Response of Cancer-Related Anemia to rHuEPO?

1 reference

12 December 2020

Factors influencing quality of life in cancer patients: anemia and fatigue.

1 reference

12 December 2020

Randomized, multicenter, controlled trial comparing the efficacy and safety of darbepoetin alpha administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia

1 reference

12 December 2020

Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states

1 reference

12 December 2020

Sarcoma after intramuscular iron injection

1 reference

12 December 2020

Iron absorption in patients with chronic uremia on maintenance hemodialysis and in healthy volunteers measured with a simple oral iron load test

1 reference

12 December 2020

Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study

1 reference

12 December 2020

Administration of parenteral iron and mortality among hemodialysis patients

1 reference

12 December 2020

Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

The incidence of cancer among blood donors

1 reference

12 December 2020

Hypersensitivity reactions and deaths associated with intravenous iron preparations

1 reference

12 December 2020

Structure, chemistry, and pharmacokinetics of intravenous iron agents

1 reference

12 December 2020

Intravenous iron and recombinant human erythropoietin in cancer patients

1 reference

12 December 2020

Guidelines and recommendations for the management of anaemia in patients with lymphoid malignancies

1 reference

12 December 2020

The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients.

1 reference

12 December 2020

Iron and the anaemia of chronic disease: a review and strategic recommendations.

1 reference

12 December 2020

Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia

1 reference

12 December 2020

Marked erythropoietin increase before fall in Hb after treatment with cytostatic drugs suggests mechanism other than anaemia for stimulation

1 reference

12 December 2020

Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease

1 reference

12 December 2020

Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha.

1 reference

12 December 2020

The Metabolism of Iron-Dextran Given as a Total-Dose Infusion to Iron Deficient Jamaican Subjects

1 reference

12 December 2020

Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury

1 reference

12 December 2020

Hypochromic erythrocytes (%): a reliable marker for recognizing iron-restricted erythropoiesis and predicting response to erythropoietin in anemic patients with myeloma and lymphoma

1 reference

12 December 2020

Update on adverse drug events associated with parenteral iron

1 reference

12 December 2020

The role of iron in cell cycle progression and the proliferation of neoplastic cells

1 reference

12 December 2020

High-dose parenteral iron sucrose depresses neutrophil intracellular killing capacity.

1 reference

12 December 2020

Non-transferrin-bound iron in the serum of hemodialysis patients who receive ferric saccharate: no correlation to peroxide generation

1 reference

12 December 2020

Evaluation of hypochromic erythrocytes in combination with sTfR-F index for predicting response to r-HuEPO in anemic patients with multiple myeloma.

1 reference

12 December 2020

Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy.

1 reference

12 December 2020

An indistinct balance: the safety and efficacy of parenteral iron therapy.

1 reference

12 December 2020

Hemosiderosis in hemodialysis patients. An autopsy study of 50 cases

1 reference

12 December 2020

Potential utility of Ret-Y in the diagnosis of iron-restricted erythropoiesis

1 reference

12 December 2020

Iron sucrose in hemodialysis patients: safety of replacement and maintenance regimens

1 reference

12 December 2020

Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial

1 reference

12 December 2020

1 reference

12 December 2020

Intravenous versus oral iron therapy for postpartum anaemia.

1 reference

12 December 2020

Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency

1 reference

12 December 2020

Canadian supportive care recommendations for the management of anemia in patients with cancer

1 reference

12 December 2020

Iron absorption during epoetin alfa therapy for chemotherapy-associated anaemia.

1 reference

12 December 2020

Pharmacokinetics and red cell utilization of 52Fe/59Fe-labelled iron polymaltose in anaemic patients using positron emission tomography

1 reference

12 December 2020

10.1007/S12032-008-9072-0

Identifiers

DOI

1 reference

18 August 2017

1 reference